Inventor
GONZALEZ LOPEZ DE TURISO FELIX
US23 patents
⚠️ This page may combine multiple inventors who share the name “GONZALEZ LOPEZ DE TURISO FELIX”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
12 patentsUS11299479B1Apr 12, 2022
Bisamide sarcomere activating compounds and uses thereof
AMGEN INC8 citations83
US9593129B2Mar 14, 2017
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
AMGEN INC5 citations83
US9296736B2Mar 29, 2016
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
AMGEN INC7 citations83
US8716290B2May 6, 2014
Heterocyclic compounds and their uses
AMGEN INC5 citations83
US10899746B2Jan 26, 2021
Bisamide sarcomere activating compounds and uses thereof
AMGEN INC5 citations82
US9376425B2Jun 28, 2016
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
AMGEN INC12 citations82
US11780826B2Oct 10, 2023
Bisamide sarcomere activating compounds and uses thereof
AMGEN INC2 citations71
US11306107B2Apr 19, 2022
Compounds that inhibit MCL-1 protein
AMGEN INC2 citations71
US9873701B2Jan 23, 2018
Heterocyclic compounds and their uses
AMGEN INC1 citations62
US8835432B2Sep 16, 2014
Heterocyclic compounds and their uses
AMGEN INC0 citations51
US11407721B2Aug 9, 2022
CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
AMGEN INC0 citations50
US9873704B2Jan 23, 2018
Heterocyclic compounds and their uses
AMGEN INC0 citations41
BIOGEN MA INC
5 patentsUS12404263B2Sep 2, 2025
ASK1 inhibiting agents
BIOGEN MA INC0 citations59
US11814362B2Nov 14, 2023
ASK1 inhibiting agents
BIOGEN MA INC1 citations59
US11897898B2Feb 13, 2024
Pyridine macrocycle compounds as ASK1 inhibiting agents
BIOGEN MA INC0 citations51
US11999715B2Jun 4, 2024
ASK1 inhibiting agents
BIOGEN MA INC0 citations50
US11168095B2Nov 9, 2021
ASK1 inhibiting agents
BIOGEN MA INC0 citations48